Edition:
United States

Alliqua BioMedical Inc (ALQA.OQ)

ALQA.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
16 Feb 2018
Change (% chg)

$0.01 (+0.58%)
Prev Close
$1.72
Open
$1.71
Day's High
$1.81
Day's Low
$1.71
Volume
2,343
Avg. Vol
15,233
52-wk High
$8.47
52-wk Low
$1.59

Chart for

About

Alliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company's businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound... (more)

Overall

Beta: 1.77
Market Cap(Mil.): $8.58
Shares Outstanding(Mil.): 4.99
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 34.52 17.27
EPS (TTM): -- -- --
ROI: -- 14.12 35.43
ROE: -- 16.75 17.10

BRIEF-Alliqua Biomedical Says Has Right To Terminate Agreement With Celularity, Provided Co Pays $1.45 Mln Fee

* ALLIQUA BIOMEDICAL SAYS HAS RIGHT TO TERMINATE ASSET PURCHASE AGREEMENT WITH CELULARITY, PROVIDED CO PAYS TERMINATION FEE OF $1.45 MILLION - SEC FILING

Jan 05 2018

BRIEF-Alliqua Biomedical Announces Definitive Asset Purchase Agreement With Celularity Inc

* ALLIQUA BIOMEDICAL, INC. ANNOUNCES DEFINITIVE ASSET PURCHASE AGREEMENT WITH CELULARITY, INC.

Jan 05 2018

BRIEF-Alliqua BioMedical engages Cowen to assist in evaluating potential strategic alternatives

* Alliqua BioMedical Inc engages Cowen to assist in evaluating potential strategic alternatives

Nov 09 2017

BRIEF-Alliqua Biomedical announces 1-for-10 reverse stock split

* Alliqua Biomedical Inc announces 1-for-10 reverse stock split

Oct 05 2017

BRIEF-Alliqua Biomedical sells TheraBond 3D Antimicrobial Barrier Systems product line

* Alliqua Biomedical Inc announces the sale of TheraBond 3D Antimicrobial Barrier Systems product line; Alliqua updates fiscal year outlook

Sep 05 2017

Earnings vs. Estimates